RHYTHM PHARMACEUTICALS, INC. business relationships
Companies named in RHYTHM PHARMACEUTICALS, INC.’s 10-K filed 2026-02-26, and public companies whose annual reports name RHYTHM PHARMACEUTICALS, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.9 / 10
- AI naming
- 23 / 100 Top 1% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Layers: PeptidesGLP-1 & obesity
Named in RHYTHM PHARMACEUTICALS, INC.’s annual report 3
“In January 2016, the Company entered into a license agreement with Camurus AB, or Camurus, for the use of Camurus' drug delivery technology.” SEC filing
“In collaboration with Camurus AB, or Camurus, we have developed a once-weekly, long-acting formulation of setmelanotide using FluidCrystal® technology.” SEC filing
“In December 2021, the Company entered into an Exclusive License Agreement with RareStone Group Ltd., or the RareStone License.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.